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2Abstract 
Investigations of apparently balanced chromosomal rearrangements in patients with 
abnormal phenotype by molecular cytogenetics tools, especially by array CGH, revealed a 
proportion of unsuspected imbalances. It was estimated recently that 40 % of apparently 
balanced de novo translocations with abnormal phenotype were associated with cryptic 
deletion. 
We explored 47 unrelated mental retardation patients carrying an apparently balanced 
chromosomal rearrangement with high-resolution oligonucleotides arrays. We included 33 de 
novo cases (21 translocations, 7 inversions and 5 complex chromosomal rearrangements 
(CCR)) and 14 inherited cases (7 translocations, 5 inversions and 2 CCR). 
Twenty of the 47 cases (42.6 %) carried a cryptic deletion ranging from 60 kb to 15.37
Mb. It concerned 16/33 de novo rearrangements (8/21 translocations, 4/7 inversions and 4/5 
CCR) and 4/14 inherited rearrangements (1/7 translocations, 2/5 inversions and 1/2 CCR). 
The proportion of imbalances was not statistically different between de novo and inherited 
cases.
Our results support that about 40 % apparently balanced chromosomal rearrangements 
with abnormal phenotype are in fact imbalanced and that these rearrangements should be 
systematically investigated by array CGH independently of their de novo or inherited 
character.
Keywords: array CGH, apparently balanced translocations, abnormal phenotype
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31. Introduction 
It is estimated that standard karyotype displayed chromosome aberrations in 3 to 15 % 
of patients affected with mental retardation [24,29,30]. Most of them are unbalanced by either 
numerical (trisomy, monosomy) or structural (deletion, duplication…) anomalies. However, 
apparently balanced structural rearrangements are present in 0.6 % of mentally retarded 
patients [24]. About 6 % of de novo apparently balanced translocations [32] and 23 % of 
apparently balanced complex chromosomal rearrangements (CCR) defined by three or more 
breakpoints [21] are associated with an abnormal phenotype. These balanced rearrangements 
were demonstrated to be responsible for the phenotype by different mechanisms such as gene 
disruption at the breakpoints [13,14], position effect [8,16,17] or disturbance of parental 
imprinting [6]. Development of Fluorescent In Situ Hybridization (FISH) or Comparative 
Genomic Hybridization (CGH) on chromosomes showed that a proportion of these 
rearrangements was in fact associated with cryptic imbalances [1,3,12,15,18,23]. More 
recently, array CGH technology [28] has been used to investigate apparently balanced 
translocations associated with an abnormal phenotype and has found cryptic deletion in about 
30 to 50 % of them [2,4,10].
Here, we explored 47 patients presenting with mental retardation and carrying an 
apparently balanced chromosomal rearrangement with high-resolution oligonucleotide array 
in order to detect cryptic imbalances accounting for the phenotype. These rearrangements 
were either de novo (33 patients) or inherited (14 patients) and included reciprocal 
translocations, peri- and paracentric inversions or CCR. We estimated their frequency and 
defined the place of this technology in a diagnostic setting.
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42. Material and methods
2.1. Patients 
Forty-seven patients (26 males and 21 females) with mental retardation and/or 
multiple congenital malformations have been included in the study after fully informed 
consent was obtained. All patients had been assessed by a clinical geneticist. Phenotype range 
was very wide and included variable degree of mental retardation with or without 
malformations and facial dysmorphism. For all of them, standard karyotype (RHG, 500 
bands) showed an apparently balanced rearrangement including 28 reciprocal translocations, 
12 inversions and 7 CCR. Thirty-three balanced rearrangements occurred de novo (21 
translocations, 7 inversions and 5 CCR) and 14 were inherited from a healthy parent (7 
translocations, 5 inversions and 2 CCR) (Table 1). There was no other evident cause for their 
phenotype. Patients' karyotypes are summed up in Table 1. Parents' blood sample was 
required to assess if the imbalances detected by array CGH were de novo or inherited.
2.2. Array CGH 
Agilent® oligonucleotide arrays were used according to the manufacturer instruction 
(Agilent Human Genome CGH Microarray kit 244A® and 44K®). The overall median probe 
spacing was 43 kb for 44K array and 8.9 kb for 244A array. Thirty eight patients DNA were 
analyzed with a 44,000 oligonucleotides array and 9 patients DNA with a 244,000 
oligonucleotides array (#1, #2, #3, #29, #30, #31, #32, #41, #42). Patient’s DNA as well as a 
reference DNA were digested with RsaI and AluI. Each digested DNA product was labelled 
by random priming using either Cy5-dUTP or Cy3-dUTP. After columns-purification, probes 
were denaturated and pre-annealed with 50 µg of human Cot-1 DNA (Invitrogen®, 
California). Hybridization was performed at 65°C during 40 hours. After washing, the array 
was scanned and analyzed with Feature Extraction® 9.1 software. Control DNA consisted 
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5either of a sex-matched pool of genomic DNA commercially available (Promega®, USA) or 
of two other patients DNA, according to the loop model [22]. Results were interpreted with 
CGH analytics® 4.5 software by two investigators. A copy number variation was considered 
if at least 3 contiguous oligonucleotides presented an abnormal log ratio (> + 0,66 or < -0,75). 
Results were compared to data recorded in the database of genomic variants.
2.3. Fluorescent in situ hybridization (FISH)
FISH analyses on patient metaphases were performed in order to confirm the results of 
array CGH. Each time a microdeletion was confirmed, FISH was performed on parents’ 
sample in order to check if the genomic imbalance was de novo or inherited. BACs were 
chosen on UCSC and Ensembl databases. FISH using BAC clones was performed as 
described by Romana et al [24]. DNA was fluoresceine or rhodamine labeled by nick-
translation. Probes were coprecipitated with human Cot-1 DNA (Invitrogen®, California) and 
then resuspended in hybridization buffer (50 % formamide). After denaturation, overnight 
hybridization and post-hybridization wash, slides were DAPI counterstained and were read 
using a fluorescent microscope equipped with a CCD camera. All details about BAC clones 
used are available on request. 
2.4. Quantitative PCR (qPCR)
When FISH was not possible, the confirmation of allelic imbalance in the target chromosome 
region was analyzed using SYBR Green I based quantitative real time PCR with Light-
Cycler® (Roche Diagnostics, GmbH, Mannheim, Germany). The protocol involved 
amplification of a target gene and a reference gene (ADORA2B, HGNC:264) (primers 
sequences available on request). Quantitative PCR protocol was conducted in triplicate in a 20 
µL final volume containing 10 µL of SYBR PCR Master Mix (2X) (Qiagen®, GmbH, Hilden, 
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6Germany), 1.5 µM of each primer and 10 ng of genomic DNA. The thermal cycling 
conditions comprised a 15 min polymerase activation at 95°C followed by 35 cycles of 15 s at 
95°C, 30 s at 60°C and 15s at 72°C. Experiments need to have a coefficient of variation for 
triplicate samples inferior to 0.1. PCR efficiency is calculated as followed:  10-1/slope. 
Efficiency of qPCR is equal to 100% when 10-1/slope = 2 meaning that quantity of DNA is 
multiplied by 2 at each cycle of the PCR. We consider that PCR efficiency do be superior to 
98% to assure good results.
A melting curve step was used to examine each sample for purity and specificity and 
the size of the amplicons was checked by electrophoresis. The calculation is based on the Ct 
values (minimal number of PCR cycles necessary to detect a fluorescence issued by the 
SYBR Green I) obtained by the Light Cycler software. A series of 5-fold dilutions of human 
genomic DNA corresponding to 0.5 to 8 ng/µL was included in each experiments in order to 
generate an external standard curve (Ct = A x log [Concentration DNA] + B) that allowed to 
estimate DNA concentration for each sample. Relative copy number is then calculated as the 
[target gene]/[reference gene] ratio.
3. Results 
Overall, array CGH demonstrated cryptic imbalances in 20 of the 47 patients (42.6%). 
It consisted of 21 deletions ranging from 60 kb to 15.37 Mb. Nine of the 21 imbalances were 
located in regions not involved in the balanced rearrangement. Two of these cryptic 
imbalances were inherited from a healthy parent. The proportion of imbalances detected in de 
novo (16/33, 48.5 %) and in inherited rearrangements (4/14, 28.6%) was not statistically 
different (p<0.34). Results and phenotypes of these patients are described in detail in Table 2.
De novo rearrangements
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7Microdeletions were detected in 16 of the 33 de novo structural rearrangements 
(48.5%). They ranged from 60 kb to 15.37 Mb and were all de novo. Nine of them were at 
distance from initial breakpoints. One patient (#42) presented two deletions.
Reciprocal translocations: 38.1 % (8/21) of apparently balanced translocations 
showed an associated deletion ranging from 60 kb to 15.37 Mb. Three of them were located at 
distance from translocation breakpoints (#1, #22, #27). 
Inversions: Four of the seven (57.1 %) de novo inversions were imbalanced. 
Microdeletions ranged from 1.06 Mb to 8.87 Mb. Three of them were located on a different 
chromosome than the chromosome carrying the inversion (#29, #34, #36). 
Complex chromosomal rearrangements: Four of the five de novo CCR were 
imbalanced (80 %) with deletions ranging from 690 kb to 4.9 Mb. Case #42 showed two 
deletions, one on a chromosome 2 at distance from the breakpoint and one on a chromosome 
6 at the breakpoint. 
Inherited rearrangements
Cryptic rearrangements were detected in 4 of the 14 inherited structural 
rearrangements (28.6%). These were only deletions ranging from 80 kb to 3.64 Mb. Two of 
them were inherited from a healthy parent (#9, #31). Two of them were at distance from 
initial breakpoints (#9, #31).
Reciprocal translocations: One of the seven (14.3 %) apparently balanced 
translocations showed a 1.21 Mb deletion at distance from the breakpoints (#9). It was 
inherited from the healthy father who also carries the balanced translocation.
Inversions: Two of the five (40 %) inversions were imbalanced. Deletion size was 
respectively of 80 kb and 1.23 Mb. One of these imbalances was located on a different 
in
se
rm
-0
04
05
48
4,
 v
er
sio
n 
1 
- 2
5 
Au
g 
20
09
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who also transmitted the inversion (#31).
Complex chromosomal rearrangements: One of the two CCR (50 %) presented a 3.64 
Mb de novo deletion. 
Results according to the array resolution
Thirty-eight cases were studied with 44K array. It displayed 15 microdeletions ranging 
from 300 kb to 15.37 Mb (mean = 4.24 Mb). Nine cases were investigated with a 244K array 
(#1, #2, #3, #29, #30, #31, #32, #41, #42). Six microdeletions in five patients were found 
ranging from 60 kb to 8.87 Mb (mean: 3.16 Mb). In two cases (#1, #31) in whom the deletion 
was of small size (less than 100 kb), it could not be concluded if the deletion accounted for 
the phenotype really. 
4. Discussion
Development of more and more accurate molecular cytogenetics techniques such as 
FISH, CGH on chromosomes and array CGH allowed to dissect apparently balanced 
chromosomal rearrangements in patients with abnormal phenotype. These techniques 
displayed the complexity of reciprocal translocations that could in fact involve up to 5 
chromosomes in a combination of translocations, insertions and inversions [1,3,10,23]. They 
also showed presence of cryptic imbalances either at the chromosomal breakpoint or at 
distance [1,3,10,12,15,18,23]. Characterization by FISH of 40 apparently balanced 
chromosomal rearrangements from the Developmental Genome Anatomy Project revealed 
imbalances in 37 % of them (15/40 cases) [12]. Array CGH is the most recent technology 
used to characterize this type of rearrangements and has the advantage over FISH approach to
investigate the entire genome and not only breakpoint regions.
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9Cryptic imbalances in apparently balanced de novo rearrangements
Beside several isolated case reports [5,11], larger studies using array CGH estimated 
the proportion of imbalances in apparently balanced de novo translocations (Table 3) [2,4,10]. 
Gribble et al. studied 10 patients using a BAC/PAC array and found 5/10 imbalances from 1.2 
to 6.2 Mb [10]. De Gregori et al investigated 59 patients including de novo reciprocal 
translocations and CCR. They showed i) that 40 % of apparently balanced translocations with 
abnormal phenotype are associated with a cryptic deletion, ii) that 18 % of them are in fact 
more complex and iii) that almost all CCR with abnormal phenotype are imbalanced [4]. 
More recently, Baptista et al found four imbalances in 14 patients (28.6 %) [2]. In the present 
study, we found cryptic deletion in 48.5 % of cases (16/33) of apparently balanced de novo
rearrangements associated with an abnormal phenotype including 8 translocations, 4 
inversions and 4 CCR. Twenty-seven percent of them revealed more complex as initially 
thought. In 15 of these cases, the phenotype could be related to the cryptic imbalance 
according to its de novo nature, its size and its gene content [19]. For example, case #43 
showed a de novo 690 kb deletion involving the TWIST gene that accounted for his Saethre-
Chotzen phenotype and was described elsewhere [26]. These results are consistent with the 
previous studies leading us to conclude that about 40 % of apparently balanced de novo
rearrangements with abnormal phenotype are associated with a cryptic imbalance. The yield 
of array CGH in MCA/MR patients with normal standard karyotype is about 10 to 17 % 
[20,27]. So it seems that genomic imbalances are more likely to be found in MCA/MR
patients with structural chromosome rearrangements than in patients without. Interestingly, no 
case of our cohort had copy-number gains, which is also consistent with the previous studies
[2,4,10]. This could be the fact of a particular mechanism generating preferentially loss of 
material. But gains of material could also be associated with milder phenotype or a different 
phenotype than MCA/MR and may not have been recruited. Finally, microdeletions unrelated 
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to the breakpoints involve about 20 % of cases [4]. However, their significance is still unclear. 
They may either be part of a complex rearrangement involving multiple breakpoints and 
fusions at different part of the genome or be associated to the balanced rearrangement 
fortuitously. 
Cryptic imbalances in apparently balanced inherited rearrangements
Four out of 14 inherited cases of chromosomal rearrangements were imbalanced: one 
translocation, 2 inversions and 1 CCR (cases #9, #31, #40 and #45). In two cases the cryptic 
imbalance occurred de novo and could be causally related to the phenotype of the patients. In 
two other cases (#9 and #31) the cryptic imbalance was inherited from the healthy parent who 
also transmitted the balanced rearrangement. So it cannot be concluded if these deletions were 
new benign variations not reported in databases yet or if they contributed to the phenotype in 
a complex manner like variable expression, unmasking of recessive mutation on the other 
allele, disturbance of parental imprinting or combination of multiple genetic defects. So, we 
believe that array CGH is also useful to explore patients with an abnormal phenotype carrying 
an inherited chromosomal rearrangement.
Diagnostic yield according to array resolution
Diagnostic yield of 244K arrays was not statistically different from 44K arrays in the 
present study. Although 244K array identified deletions less than 100 kb in two cases (cases 
#1 and #31), it was not possible to conclude about their pathological significance. Indeed, 
these deletions included a single gene, neither referenced in databases of genomic variants nor 
morbid databases (OMIM). Investigations to confirm the role of these genes in the phenotype 
of patients are time-consuming and go beyond the means of a diagnostic laboratory. The
smallest deletion detected by 44K was 300 kb in this series (case #22). Moreover, it has 
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already been demonstrated that 44K array detected as much as pathological imbalances than 
244K array but detected less copy number polymorphisms [7]. So, the use of 44K arrays 
seems compatible in a high-throughput diagnostic setting since it provides a good diagnostic 
yield and avoids too many false positive cases and time-consuming verifications.
Conclusion
In conclusion, we studied 47 cases of MCA/MR patients presenting an apparently 
balanced chromosomal rearrangement either de novo or inherited by array CGH. Genomic 
imbalances were identified in 48.5 % of de novo cases and 28.6 % of inherited cases. These 
results support previous studies showing that 40 % of patients with MCA/MR and an 
apparently balanced translocation carry a cryptic imbalance that can account for the 
phenotype. We suggest that the management of MCA/MR patients with an apparently 
balanced chromosome rearrangement should include a systematic investigation by array 
CGH, whatever the type of rearrangements (translocation, inversion or CCR) and whatever 
the inheritance (de novo or familial). If array CGH fails to detect any imbalance, breakpoints 
should be investigated to look for position effect [8,16,17] or gene disruption [13,14] that 
occurs in 35% to 50% of balanced rearrangements [2,9]. Of course, a fortuitous association 
between a balanced rearrangement and MCA/MR of another etiology cannot be excluded. In 
prenatal diagnosis, array CGH should be proposed to fetuses presented an apparently balanced 
de novo chromosomal rearrangement associated to malformations according to the literature 
[4].
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Legends to Tables 
Table 1: Conventional karyotypes of the 47 patients
Table 2: Array CGH results in patients carrying an imbalance and corresponding phenotype 
Table 3: Review of the literature and comparison with the present study
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Table 1: Conventional karyotypes of the 47 patients
Case Karyotype Inheritance Array resolution 
1 46,XY,t(1;18)(q11.1;q12.1) dn 244K
2 46,XX,t(1;18)(p36;q21) dn 244K
3 46,XY,t(4;22)(q21;q12) dn 244K
4 46,XY,t(3;5)(q24;q21) pat 44K
5 46,XX,t(10;11)(p14;p15) dn 44K
6 46,XY,t(4;11)(q27;q22;3) dn 44K
7 46,XY,t(12;14)(q21;q31) dn 44K
8 46,XY,t(7;10)(q3?5;q25?) dn 44K
9 46,XY,t(2;6)(q36;q26) pat 44K
10 46,XY,t(2;12)(p16;q14) dn 44K
11 46,X,t(Y;2)(q12;p24) dn 44K
12 46,XX,t(8;18)(q21;q22) dn 44K
13 46,XX,t(5;14)(q34;q31) dn 44K
14 46,XX,t(4;11)(q3?2;q25) dn 44K
15 46,XY,t(1;4)(q43;q22) mat 44K
16 46,XY,t(2;9)(q37.2;p23) pat 44K
17 46,XY,t(2;9)(q32;q13) dn 44K
18 46,XY,t(5;12)(q34;q23) dn 44K
19 46,XY,t(7;14)(p14;q21) mat 44K
20 46,XX,t(2;5)(p22;q12) dn 44K
21 46,XY,t(9;12)(p23;q21) dn 44K
22 46,XX,t(2;18)(p15;q21) dn 44K
23 46,XX,t(1;18)(p31;q12.3) mat 44K
24 46,XX,t(1;11)(q12;q13) mat 44K
25 46,XX,t(1;14)(q31;q12) dn 44K
26 46,XY,t(2;8)(q22;q24.2) dn 44K
27 46,XY,t(7;12)(p11;p11) dn 44K
28 46,XY,t(1;6)(q4?1;q1?4) dn 44K
29 46,XX,inv(8)(p22q12.2) dn 244K
30 46,XY,inv(11)(p15q13) mat 244K
31 46,XY,inv(4)(p13q22) pat 244K
32 46,XX,inv(8)(q21q24.2) pat 244K
33 46,XX,inv(1)(q42q44) dn 44K
34 46,XX,inv(4)(p16q32) dn 44K
35 46,XX,inv(13)(q12.13q34) dn 44K
36 46,XY,inv(7)(p13q21) dn 44K
37 46,XY,inv(2)(p13q13) dn 44K
38 46,X,inv(X)(p21.1q21.1) dn 44K
39 46,XY,inv(7)(p14q21.1) mat 44K
40 46,XX,inv(1)(p21q13) mat 44K
41 46,XY,t(1;7;11)(p35;q33;q12) dn 244K
42 46,XX,t(2;3;6)(q21;q22;p26.1) dn 244K
43 46,XY,t(2;7)(p24;p21),ins(7)(p21.3q21.3q22) dn 44K
44 46,XY,inv(5)(p14q23)t(1;inv(5))(p21;q23) pat 44K
45 46,XX,ins(7;4)(q31;q27q32) mat 44K
46
46,XX,t(2;5;10)(2pter®2q22::2q34®2qter; 
5pter®5q21::2q22®2q33::10p14®10pter;10qter
®10p14::2q33®2q34::5q21®5qter)
dn 44K
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46,XX,t(1;2;9)(1pter®1q31::9p12®9pter; 
2pter®2q24::1q41®1qter;9qter®9p12: 
:1q31®1q41::2q24®2qter),t(11;14)(q11;q23)
dn 44K
dn: de novo ; pat: paternal; mat: maternal
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Table 2: Array CGH results in patients carrying an imbalance and corresponding phenotype
a) de novo rearrangement group
Case Karyotype Rearranged region Inheritance Size Mb Phenotype
1* 46,XY,t(1;18)(q11.1;q12.1) del(14)(q32.2q32.2) dn 0.06
Moderate mental retardation, macrosomia, leukodystrophy, 
hexadactyly 
3 46,XY,t(4;22)(q21;q12) del(4)(q21.22q21.22) dn 0.77 Moderate mental retardation, facial dysmorphism
8 46,XY,t(7;10)(q3?5;q25?) del(7)(q35q36.1) dn 5.13
Severe mental retardation, autistic troubles, seizures, facial 
dysmorphism
17 46,XY,t(2;9)(q32;q13) del(9)(q21.13q21.31) dn 6.49 Mild mental retardation, speech delay, facial dysmorphism, hirsutism
21 46,XY,t(9;12)(p23;q21) del(9)(p24.2p23) dn 11.61
Severe mental retardation, speech delay, aggressivity, muscular 
hypotonia, hydronephrosis, cryptorchidism, diabetes
22* 46,XX,t(2;18)(p15;q21) del(2)(p21p21) dn 0.30
Mental retardation, speech delay, hyperactivity, facial dysmorphism, 
cleft lip and palate, congenital cardiac defect, syndactyly
25 46,XX,t(1;14)(q31;q12) del(1)(q25.2q31.2) dn 15.37
Moderate mental retardation, hypotonia, growth retardation, facial 
dysmorphism, trigonocephaly
27* 46,XY,t(7;12)(p11;p11) del(2)(q33.1q33.1) dn 2.02
Severe mental retardation, autistic troubles, growth retardation, facial 
dysmorphism, microcephaly, dental anomalies
29* 46,XX,inv(8)(p22q12.2) del(1)(q24.1q24.2) dn 8.87
Mild mental retardation, seizures, growth retardation, facial 
dysmorphism
34* 46,XX,inv(4)(p16q32) del(13)(q12.3q13.1) dn 3.52
Moderate mental retardation, speech delay, obesity, facial 
dysmorphism, camptodactyly
35 46,XX,inv(13)(q12.13q34) del(13)(q12.3q13.1) dn 3.85
Severe mental retardation, microcephaly, muscular hypertonia, 
growth retardation,  liver steatosis
36* 46,XY,inv(7)(p13q21) del(14)(q22.1q22.1) dn 1.06 Mild mental retardation, spasticity, poor motor coordination
del(2)q34q34) dn 4.3
del(6q25.1q25.2) dn 4.9
43 46,XY,t(2;7)(p24;p21),ins(7)(p21.3q21.3q22) del(7)(p21.3p21.3) dn 0.69
Mild mental retardation, craniosynostosis, syndactyly (Saethre-
Chotzen syndrome), cryptorchidism,  kidney hypoplasia
46 46,XX,t(2;5;10) del(2)(q33.3q33.3) dn 3.64
Facial dysmorphism, congenital cardiac defect, brain malforamtion,  
hepatosplenomegaly, cryptorchidism
47 46,XX,t(1;2;9),t(11;14)(q11;q23) del(1)(q23.3q24.2) dn 3.57
Mental retardation, muscular hypotonia, growth retardation, facial 
dysmorphism, corpus callosum hypoplasia, renal hypoplasia, anal 
anteposition, sacrococcygeal dimple
b) inherited rearrangement group
Case Karyotype Rearranged region Inheritance Size Mb Phenotype
9* 46,XY,t(2;6)(q36;q26)pat del(6)(q24.2q24.3) pat 1.21 Autistic troubles
31* 46,XY,inv(4)(p13q22)pat del(15)(q21.3q21.3) pat 0.08
Mild mental retardation, seizures, growth retardation, facial 
dysmophism, brachymesophalangia 
40 46,XX,inv(1)(p21q13)mat del(1)(p21.2p21.2) dn 1.23 Severe mental retardation, microcephaly, facial dysmorphism
45 46,XX,ins(7;4)(q31;q27q32)mat del(4)(q31.3q32.1) dn 4.03 Moderate mental retardation, seizures, scoliosis
Transloc: translocation; Inv: inversion: CCR: complex chromosomal rearrangement; dn: de novo; pat: paternal; mat: maternal; Mb: megabases
Patients carrying a deletion unrelated to the balanced rearrangement breakpoint are marked by an asterix. 
46,XX,t(2;3;6)(q21;q22;p26.1)
Moderate mental retardation , seizures, facial dysmorphism, fingers 
hyperlaxity
42*
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Table 3: Review of the litterature and comparison with the present study
Gribble et al.[10] De Gregori et al.[4] Baptista et al.[2] 
Array BAC/PAC Oligonucleotides BAC/PAC
Resolution 3,500 clones 44K/244K 30,000 clones
Rearrangements t/CCR t/CCR t
de novo /inherited de novo de novo de novo de novo inherited
Number of patients 10 59 14 33 14
Rate imbalance 50% (5/10) 45.7% (24/59) 28.6 %(4/14) 48.5 % (16/33) 28.6% (4/14)
Imbalance size (Mb) 2.2-6.2 0.5-8.4 0.17-2.5 0.06-15.37 0.08-3.64
Imbalance at distance 
from breakpoint
60% (3/5) 41.6% (10/24) 25% (1/4) 56.2% (9/16) 50% (2/4)
t: translocation; CCR: complex chromosomal rearrangement; inv: inversion
Present study
Oligonucleotides
44K/244K
t/inv/CCR
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